Raymond James Financial (FRA:RJF) Research & Development: €0 Mil (TTM As of Mar. 2026)


FRA:RJF Raymond James Financial Inc FRA:RJF
80 GF Score
Price €130.05
GF Value €146.35
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Raymond James Financial Research & Development?

Raymond James Financial FRA:RJF -4.23% 80 Research & Development is €0 Mil as of Mar. 2026. GuruFocus rates FRA:RJF with a GF Score™ of 80/100 and a GF Value™ of €146.35 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Raymond James Financial's Research & Development for the three months ended in Mar. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0 Mil.

Raymond James Financial  (FRA:RJF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Raymond James Financial Research & Development Related Terms

Raymond James Financial Research & Development Historical Data

* Premium members only.

The historical data trend for Raymond James Financial's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raymond James Financial Research & Development Chart

Raymond James Financial Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Raymond James Financial Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:RJF
80GF Score
Raymond James Financial Inc FRA:RJF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Raymond James Financial Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Raymond James Financial (FRA:RJF) has a Research & Development of €0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Raymond James Financial and its competitors.
Is Raymond James Financial's Research & Development too high?
Raymond James Financial's current Research & Development is €0 Mil. Overall, Raymond James Financial has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raymond James Financial's Research & Development compare to ARES and NTRS?
Raymond James Financial's Research & Development of €0 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Raymond James Financial and its competitors. Raymond James Financial's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raymond James Financial stock overvalued right now?
Based on GuruFocus' analysis, Raymond James Financial (FRA:RJF) is currently considered Modestly Undervalued. The stock's GF Value™ is €146.35, compared to a current price of €130.05 — trading 11.1% below its estimated fair value. The current Research & Development is €0 Mil. Raymond James Financial's overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Raymond James Financial (FRA:RJF), the current Research & Development is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Raymond James Financial (FRA:RJF) Overvalued in 2026?

Based on GuruFocus' analysis, Raymond James Financial stock appears to be undervalued. The current stock price of €130.05 is trading 11.1% below its estimated GF Value™ of €146.35. GuruFocus considers Raymond James Financial to be Modestly Undervalued.

Key valuation signals for FRA:RJF:

  • Research & Development: €0 Mil
  • GF Value™: €146.35 vs. price of €130.05 (11.1% below fair value)
  • GF Score™: 80/100 with 1 warning sign

No single metric tells the full story. See the FRA:RJF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Raymond James Financial Business Description

Address 880 Carillon Parkway, Saint Petersburg, FL, USA, 33716
Raymond James Financial is a diversified financial services firm that provides wealth management, investment banking, asset management, and capital markets services to individuals, corporations, and municipalities. The firm maintains an extensive catalogue of products and services across its business lines. However, the wealth management franchise generates the bulk of its revenues and earnings through a vast network of more than 8,900 independent and employee-affiliated advisors, who collectively managed over $1.7 trillion in client assets as of fiscal year-end 2025. While Raymond James maintains a global footprint, the company derives over 90% of its revenue and an even larger percentage of its operating income, from the United States.
80GF Score

Get the complete analysis for FRA:RJF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€130.05
Price
€146.35
GF Value